Hellenic Journal οf Radiology

Central Nervous System, Magnetic Resonance Imaging, Perfusion Imaging, Diffusion, Lymphoma, Multiple Sclerosis

Partovi S, Karimi S, Lyo JK, et al. Multimodality imaging of primary CNS lymphoma in immunocompetent patients. Br J Radiol 2014; 87(1036): 20130684.

Brandsma D, Bromberg JEC. Primary CNS lymphoma in HIV infection. Handbook of Clinical Neurology 2018; 152: 177-186.

Abddoli M, Freedman MS. Neuro-oncology dilemma: tumor or tumefactive demyelinating lesion. Mult Scler Relat Disord 2015; 4(6): 555-566.

Lin X, Yu WY, Liauw L, et al. Clinicoradiologic Features distinguish tumefactive multiple sclerosis form CNS neoplasms. Neurol Clin Pract 2017; 7(1): 53-64.

Hyland M, Bermel RA, Cohen JA, et al. Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions. Neurol Clin practice 2013; 3(1): 15–21.

Mabray MC, Cohen BA, Villanueva-Meyer JE, et al. Performance of apparent Diffusion Coefficient Values and conventional MRI features in differentiating tumefactive demyelinating lesions from primary brain neoplasms. AJR Am J Roentgenol 2015; 205: 1075-1085.

Suh CH, Kim HS, Jung SC, et al. MRI findings in tumefactive demyelinating lesions: A systematic review and Meta –Analysis. AJNR 2018; (9): 1643-1649.

Parks NE, Bhan V, Shankar JJ. Perfusion imaging of tumefactive demyelinating lesions compared to high grade gliomas. Can J Neurol Sci 2016; 43: 316-318.

Cianfoni A, Niku S, Imbesi SG. Metabolite findings in tumefactive demyelinating lesions utilizing Short Echo Time Proton Magnetic Resonance Spectroscopy. AJNR 2007; (2): 272-277.

Algahtani H, Shirah B, Alassiri A. Tumefactive demyelinating lesions: A comprehensive review. Mult Scler Disod